Company Profile
Since it’s beginning as one of the world’s first cardiac core labs, Cardiocore, has delivered worldwide leadership in scientific consulting, service provision and data management. Its centralized services include electrocardiography (ECG), Holter monitoring, ambulatory blood pressure monitoring (ABPM), echocardiography (ECHO), multigated acquisition scan (MUGA), protocol development, expert reporting and statistical analysis.
Cardiocore’s scientific leadership team comprises four international thought leaders and two of the cardiac testing industry’s founding fathers. This expert consultancy offers up-to-date regulatory assistance, ECG, Holter, and ECHO/MUGA protocol development services, deep experience in Thorough QT study design and cardiac testing for oncology.
The company’s advanced data management systems enable complete customization for sponsors’ preferred data specifications. Its powerful web service, the CardioPortal™, provides real time access to rich data from any web browser, without client-side plug-ins. And Cardiocore’s HolterGateway™ provides GCP compliant digital transfer of Holter data, eliminating risky data transfers by courier.
Cardiocore’s global experience includes Phase I-IV and Thorough QT trials for Top Ten pharmaceutical organizations, specialty pharmaceutical firms and emerging biotech companies. The company’s globally distributed core lab locations near Washington, DC, South San Francisco, CA, London, UK, and Singapore, support sponsors and sites in Eastern and Western Europe, Russia and Asia-Pacific, North and South America, Africa and the Middle East.
